GLENMEDE TRUST CO NA

Bank

Position in INCY — Incyte Corp

CIK 314949 PHILADELPHIA, PA

Position in INCY

as of Mar 31, 2026 · filed May 26, 2026 Compact

Position Value

$49,252,148

-$4,973,174 QoQ

Shares Held

523,291

-4.7% QoQ

Ownership

0.262%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 99.2994337758532.ToString("F0")% Shared 0.ToString("F0")% None 0.700566224146794.ToString("F0")%

Healthcare · as of Mar 31, 2026

GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. INCY ranks #1 (40.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp This page	523,291	$49,252,148
2	CPRX	Catalyst Pharmaceuticals, Inc.	565,424	$13,999,896
3	REGN	Regeneron Pharmaceuticals, Inc.	18,059	$13,953,104
4	HALO	Halozyme Therapeutics, Inc.	146,717	$9,482,319
5	ACAD	Acadia Pharmaceuticals Inc	405,892	$9,035,155
6	VRTX	Vertex Pharmaceuticals Inc / Ma	5,608	$2,504,195
7	JAZZ	Jazz Pharmaceuticals plc	7,819	$1,478,181
8	AXSM	Axsome Therapeutics, Inc.	6,716	$1,135,138

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$49,252,148	523,291	-4.7%	Shares	Sole	2026-05-26
2025-12-31	$54,225,322	549,006	-12.8%	Shares	Sole	2026-02-17
2025-03-31	$38,142,018	629,926	-1.1%	Shares	Sole	2025-05-15
2024-12-31	$43,995,517	636,970	-8.6%	Shares	Sole	2025-02-14
2024-09-30	$46,073,351	697,025	-18.4%	Shares	Sole	2024-11-13
2024-06-30	$51,768,691	853,987	+67892.6%	Shares	Defined	2024-08-14
2020-09-30	$112,713	1,256	+7.1%	Shares	Defined	2020-11-16
2020-06-30	$121,956	1,173	+24.4%	Shares	Defined	2020-08-14
2020-03-31	$69,055	943	—	Shares	Defined	2020-05-20
No filing history on record for this holder in this stock.